Does Baby Aspirin Help With High Blood Pressure?

Baby aspirin does not lower blood pressure. A 2024 meta-analysis pooling data from more than 20,000 patients found no meaningful change in either systolic or diastolic blood pressure in people taking aspirin compared to those taking a placebo. The confusion is understandable, though, because aspirin is deeply tied to heart health and is often prescribed alongside blood pressure medications. But “good for your heart” and “lowers blood pressure” are different claims, and the distinction matters more than most people realize.

What the Evidence Shows About Blood Pressure Numbers

The most direct test of whether aspirin affects blood pressure readings comes from a systematic review and meta-analysis published in 2024 in BMC Cardiovascular Disorders. Researchers pooled five studies covering 20,312 hypertensive patients and found that aspirin changed systolic blood pressure by less than one point on average, and diastolic blood pressure by less than one point as well. Neither change was statistically significant, meaning the numbers were indistinguishable from what you would expect by chance alone.¹ If you are taking baby aspirin hoping it will bring your readings down, this is the key finding: it will not.

There is one narrow exception worth mentioning. A small study in the late 1980s looked at patients with renovascular hypertension, a specific condition where narrowed arteries to the kidneys drive blood pressure up through a hormone chain. When those patients received intravenous aspirin, their mean arterial pressure dropped from about 120 to 110 mmHg. But this involved a particular type of hypertension driven by kidney hormone overproduction, intravenous delivery rather than a pill, and a dose far higher than what you would find in baby aspirin.² It is interesting from a biological standpoint, but it does not apply to the vast majority of people with high blood pressure.

Where the Confusion Comes From

Much of the mix-up traces to the Hypertension Optimal Treatment trial, commonly called HOT, one of the largest studies ever conducted in hypertensive patients. The trial enrolled nearly 19,000 people aged 50 to 80 with elevated diastolic blood pressure and randomly assigned them to either 75 mg of aspirin daily or placebo, on top of blood pressure-lowering medications. The results, published in The Lancet, showed that aspirin reduced major cardiovascular events by about 15% and cut heart attacks by 36%.³ Those are impressive numbers, and they led many physicians to start prescribing low-dose aspirin to their hypertensive patients.

But aspirin achieved those results not by lowering blood pressure. It prevented clotting events. Blood pressure medications in the trial did the actual work of bringing numbers down. Aspirin added a separate layer of protection by making platelets less sticky, which reduced the chance of a clot blocking a narrowed artery. The HOT trial’s conclusion was that aspirin plus blood pressure control worked better than blood pressure control alone for preventing heart attacks, not that aspirin itself was a blood pressure treatment.⁴ The distinction is easy to lose in a headline, and it is probably the single biggest reason people believe baby aspirin helps with high blood pressure.

The Bedtime Aspirin Theory

One line of research has explored whether taking aspirin at bedtime rather than in the morning might produce a small blood pressure benefit. A randomized controlled trial in high-risk cardiovascular patients compared morning and evening aspirin and found that evening dosing was associated with a favorable shift in ambulatory blood pressure patterns and an improved day-to-night blood pressure profile.⁵

This finding generated a lot of interest, but it needs some context. The effect was modest, the study population was already on cardiovascular medications, and larger confirmatory trials have not established bedtime aspirin as a blood pressure strategy. If your doctor has prescribed aspirin for a cardiovascular reason, asking about timing is reasonable. But nobody should start taking aspirin at bedtime specifically to lower their blood pressure based on this evidence alone.

Why Current Guidelines Have Pulled Back on Aspirin

For decades, low-dose aspirin was a near-universal recommendation for adults at risk of heart disease. That era is fading. The U.S. Preventive Services Task Force updated its guidance and now recommends against starting aspirin for primary prevention in adults 60 or older. For adults 40 to 59 with elevated cardiovascular risk, the task force says the decision should be individualized because the net benefit is small.⁶ These recommendations apply to people without existing cardiovascular disease who are not already at increased risk for bleeding.

The shift happened partly because the trials that originally supported aspirin for primary prevention were done in an era when fewer people were on statins, blood pressure medications, and other modern treatments. Three major trials published around 2018 and 2019 tested aspirin in contemporary populations who were already getting better background care, and the results were disappointing. The ASPREE trial, which enrolled over 19,000 healthy older adults, found that aspirin did not reduce disability-free survival and raised the risk of major bleeding by about 38%.⁷ A companion paper from the same trial reported that aspirin did not significantly reduce cardiovascular events in this group but did cause more major hemorrhages.⁸

The upshot: if you have high blood pressure but have never had a heart attack or stroke, starting baby aspirin on your own is not clearly helpful and carries real risks. If you have already had a cardiovascular event, aspirin for secondary prevention is a different conversation entirely and generally remains recommended. The primary prevention picture, though, has become much more cautious.

Bleeding Risks Are Higher When Blood Pressure Is Uncontrolled

The biggest concern with aspirin is bleeding, and having high blood pressure makes the risk worse. A study of elderly patients with multiple cardiovascular risk factors found that aspirin had no effect on the primary cardiovascular outcome in any blood pressure subgroup. But in the group with high blood pressure, aspirin was linked to a more than threefold increase in hemorrhagic stroke.⁹ That is the worst possible combination: no cardiovascular benefit and a dramatically elevated risk of the most dangerous type of bleeding event.¹⁰

Beyond stroke, gastrointestinal bleeding is the most common aspirin-related complication. Long-term aspirin use raises the risk of GI bleeding by roughly 50 to 90% depending on the population studied.¹¹ The risk is higher in people using aspirin for primary prevention than in those using it for secondary prevention, likely because the underlying baseline risk profiles differ.¹² Several factors stack the odds further against you: a history of ulcers, older age, taking other anti-inflammatory drugs at the same time, or being on blood thinners.¹³

Aspirin and ACE Inhibitors Can Work Against Each Other

Many people with high blood pressure take ACE inhibitors, one of the most commonly prescribed classes of blood pressure drugs. There has been a long-running concern that aspirin may blunt some of the beneficial effects of these medications. Both drugs affect a shared pathway involving prostaglandins, signaling molecules that help blood vessels relax. ACE inhibitors boost prostaglandin production indirectly, while aspirin suppresses it.¹⁴

Clinical data suggest the interaction is dose-dependent. At higher aspirin doses (300 mg or more), there appears to be a measurable reduction in the blood pressure-lowering and hemodynamic effects of ACE inhibitors in patients with heart failure. At low doses, more typical of baby aspirin, the effect seems to be minimal or absent.¹⁵ This is reassuring for people on both medications, but it is another reason to stick with the lowest effective aspirin dose and not to assume more is better.

The concern does not appear to extend to another class of blood pressure drugs called angiotensin receptor blockers. These medications work through a different mechanism that does not rely on the prostaglandin pathway aspirin interferes with, so the theoretical basis for an interaction is weak.

Aspirin Resistance Is More Common in Hypertensive Patients

Not everyone responds to aspirin the same way. Some people’s platelets remain stubbornly sticky despite regular aspirin use, a phenomenon called aspirin resistance. Research in hypertensive patients has found that aspirin resistance may be more common in this group than in people with normal blood pressure. One study of patients with stable coronary artery disease found that aspirin resistance was significantly more frequent in those with hypertension compared to those without it.¹⁶

The practical significance is still being worked out, but the risk factors for aspirin resistance in hypertensive patients include female sex, higher creatinine levels (a marker of kidney function), and lower platelet counts.¹⁷ If you are taking baby aspirin for cardiovascular protection and have high blood pressure, this research suggests the protection may be less reliable than assumed, particularly if you also have early kidney problems. Routine testing for aspirin resistance is not standard practice, but it is something researchers continue to study.

The Pregnancy Exception

There is one important clinical scenario where low-dose aspirin is actively recommended for people at risk of a blood pressure problem: preeclampsia in pregnancy. Preeclampsia is a dangerous condition involving new-onset high blood pressure and organ damage during pregnancy, and aspirin started early enough can reduce the risk.

A systematic review for the U.S. Preventive Services Task Force found that aspirin reduced the risk of preeclampsia by about 15% across 16 randomized trials.¹⁸ The benefit was even more striking for preterm preeclampsia, the more dangerous early-onset form. A separate meta-analysis found that when aspirin was started at or before 16 weeks of pregnancy at a dose of 100 mg or more daily, it reduced preterm preeclampsia risk by roughly two-thirds.¹⁹

This is one context where aspirin genuinely helps prevent a blood pressure condition, though it works by improving placental blood flow rather than lowering blood pressure through the usual mechanisms. The timing matters: starting aspirin after 16 weeks appears to be much less effective. Despite the evidence, a qualitative study found that pregnant people often face confusion about why aspirin is recommended, sometimes hear conflicting information from different providers, and may not understand the time-sensitive nature of the prescription.²⁰ If you are pregnant and have been told to take low-dose aspirin, the evidence supporting it is solid, and starting early is the key.

Aspirin and Kidney Health in People With High Blood Pressure

High blood pressure is one of the leading causes of chronic kidney disease, and many people with both conditions take aspirin. The assumption that aspirin is harmless in this population deserves scrutiny. A study using machine learning to analyze outcomes in patients with advanced chronic kidney disease who had not yet started dialysis found that aspirin use was associated with a higher risk of progressing to dialysis and a higher risk of dying before reaching dialysis.²¹

Animal research adds a layer of nuance. In hypertensive rats, high-dose aspirin improved heart and blood vessel function but simultaneously worsened kidney inflammation and fibrosis and actually raised blood pressure. A lower dose preserved the heart benefits while avoiding the kidney damage and blood pressure elevation.⁹ Animal studies do not translate directly to humans, but the pattern reinforces the idea that dose matters and that aspirin is not a simple “take it and forget it” medication for people with both high blood pressure and kidney disease. If your kidneys are already compromised, the decision to use aspirin is one that deserves an explicit conversation with your doctor rather than a quiet over-the-counter assumption.